Rituxan (rituximab) - Roche
Rituximab in Refractory Non-Infectious Uveitis, Scleritis, and Idiopathic Orbital Inflammatory Syndrome: A Real-World Single-Centre Retrospective Case Series from Türkiye. (PubMed, Ocul Immunol Inflamm) - Sep 26, 2026 - "Absent visual gain likely reflects pre-existing damage. Because most patients continued an antimetabolite with corticosteroid premedication, the independent effect of RTX cannot be isolated." 
Journal • Real-world evidence • Retrospective data • CNS Disorders • Herpes Zoster • Immunology • Inflammation • Inflammatory Arthritis • Lupus • Multiple Sclerosis • Ocular Inflammation • Ophthalmology • Rare Diseases • Rheumatoid Arthritis • Rheumatology • Sarcoidosis • Scleritis • Uveitis • Varicella Zoster • Vasculitis
http://www.ncbi.nlm.nih.gov/pubmed/42789551
 
Mehmet Engin Tezcan; Murat Oklar; Nilüfer Zorlutuna Kaymak
 
Sep 26, 2026
 
Prev Next